MONTREAL - A
class-action lawsuit brought on behalf of investors against
Valeant Pharmaceuticals Inc. will go to trial. The Quebec Court of Appeal dismissed applications for leave to appeal from the defendants, who asked the court to review a Quebec Superior Court judge's authorization of the suit. The class action was brought on behalf of persons who acquired securities of
Valeant (TSX:VRX) outside the United States between Feb. 28, 2013 and Oct. ...
أكثر...